BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
2751 Citations•2021•
Noa Dagan, Noam Barda, Eldad Kepten
This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19–related outcomes, a finding consistent with that of the randomized trial.
Abstract
This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19-related outcomes, a finding consistent with that of the randomized trial.